PAG
TRIB

Private Advisor Group’s Trinity Biotech TRIB Stock Holding History

Private Advisor Group’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-13
Closed -$4K – 3272
2020
Q2 		$4K Buy
+13
New +$2.97K ﹤0.01% 3362

Other funds holding TRIB

HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Private Advisor Group's TRIB Position: Q3 2020 in Review

Private Advisor Group sold out of Trinity Biotech (TRIB) in Q3 2020, closing a stake of 13 shares — an estimated $4K sold.

Private Advisor Group first reported a position in TRIB in Q2 2020 and held it in 1 quarter. The position peaked at $4K in Q2 2020. 23 funds tracked by Wall St. Rank hold TRIB as of Q3 2020.

  • Private Advisor Group reported no remaining Trinity Biotech position as of Q3 2020 after selling out during the quarter.
  • Private Advisor Group sold 13 Trinity Biotech shares in Q3 2020, an estimated $4K.
  • Private Advisor Group first reported a position in Trinity Biotech in Q2 2020 and held it in 1 quarter.
  • Private Advisor Group's Trinity Biotech position peaked at $4K in Q2 2020.
  • 23 funds tracked by Wall St. Rank held Trinity Biotech as of Q3 2020.

Based on Private Advisor Group's 13F filing for Q3 2020, filed 2 Nov 2020.